We are live on ! Find out more
XENT

Intersect ENT, Inc
XENT

Delisted

XENT was delisted on the 12th of May, 2022.

Back to rankings

140 hedge funds and large institutions have $792M invested in Intersect ENT, Inc in 2017 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 44 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,846% more call options, than puts

Call options by funds: $5.04M | Put options by funds: $259K

92% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 13

17% more capital invested

Capital invested by funds: $678M → $792M (+$114M)

16% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 44

9% more funds holding

Funds holding: 128 → 140 (+12)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
140
Holders Change
+12
Holders Change %
+9.38%
% of All Funds
3.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
25
Increased
51
Reduced
44
Closed
13
Calls
$5.04M
Puts
$259K
Net Calls
+$4.78M
Net Calls Change
+$2.57M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$27.8M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$15.8M
3
PHS
PFM Health Sciences
California
+$11.1M
4
AllianceBernstein
AllianceBernstein
Tennessee
+$11.1M
5
CM
Castleark Management
Illinois
+$8.4M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$18.3M
2
PC
Paulson & Co
New York
-$15.6M
3
Millennium Management
Millennium Management
New York
-$15.4M
4
FLAM
First Light Asset Management
Minnesota
-$3.06M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
PVI
26
Pura Vida Investments
New York
$6.23M +$74.1K +2,502 +1%
DCM
27
Driehaus Capital Management
Illinois
$6.08M -$153K -5,179 -3%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$5.64M -$114K -3,865 -2%
NI
29
Numeric Investors
Massachusetts
$5.42M +$1.66M +56,100 +48%
Citigroup
30
Citigroup
New York
$5.35M +$2.08M +70,406 +70%
FLAM
31
First Light Asset Management
Minnesota
$5.3M -$3.06M -103,448 -38%
EI
32
EAM Investors
California
$5.12M +$52.6K +1,776 +1%
WRF
33
Waddell & Reed Financial
Kansas
$4.9M – – –
CWG
34
C WorldWide Group
Denmark
$4.57M -$37.6K -1,272 -0.9%
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$4.28M +$362K +12,243 +10%
Invesco
36
Invesco
Georgia
$4.17M +$3.96M +133,954 New
Allianz Asset Management
37
Allianz Asset Management
Germany
$3.98M +$8.38K +283 +0.2%
TCIM
38
TIAA CREF Investment Management
New York
$3.98M -$348K -11,741 -8%
Fiera Capital (Canada)
39
Fiera Capital (Canada)
Quebec, Canada
$3.74M +$3.55M +119,985 New
Charles Schwab
40
Charles Schwab
California
$3.6M +$613K +20,700 +22%
PPA
41
Parametric Portfolio Associates
Washington
$3.34M +$932K +31,501 +42%
Two Sigma Investments
42
Two Sigma Investments
New York
$3.17M +$205K +6,936 +7%
RA
43
Royce & Associates
New York
$2.93M – – –
RJA
44
Raymond James & Associates
Florida
$2.9M +$156K +5,264 +6%
Goldman Sachs
45
Goldman Sachs
New York
$2.81M -$990K -33,463 -27%
IHM
46
Iguana Healthcare Management
New York
$2.8M +$592K +20,000 +29%
MOACM
47
Mutual of America Capital Management
New York
$2.79M -$438K -14,800 -14%
ARTA
48
A.R.T. Advisors
New York
$2.39M +$1.24M +41,978 +120%
OAM
49
Oxford Asset Management
United Kingdom
$2.37M +$2.32M +78,367 New
PP
50
PDT Partners
New York
$2.16M – – –
1
2
3 4 5

XENT Hedge Fund Activity: Q3 2017 in Review

140 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q3 2017, worth a combined $792M — up 17% from $678M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new XENT positions and 13 closed out — a net gain of 12 holders — while 51 added to existing stakes and 44 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $27.8M. The largest seller was Jennison Associates, cutting an estimated $18.3M.

  • 140 institutional investors held Intersect ENT, Inc (XENT) as of Q3 2017, up from 128 in Q2 2017.
  • Funds reported $792M of Intersect ENT, Inc stock for Q3 2017, up 17% quarter-over-quarter.
  • 25 funds opened new Intersect ENT, Inc positions in Q3 2017 and 13 closed out, a net change of +12 holders.
  • The largest Intersect ENT, Inc buyer in Q3 2017 was Fidelity Investments, an estimated $27.8M added.
  • The largest Intersect ENT, Inc seller in Q3 2017 was Jennison Associates, an estimated $18.3M sold.

Based on aggregated 13F filings for Q3 2017.